CN 100

12/01/1986 - "CN-100 also exerted an evident preventive effect on destruction of foot bone, improved the changes in organ weight, and stimulated weight gain. "

12/01/1986 - "CN-100 inhibited the sustained edema induced by mustard, but the drug did not interfere with the increase in body weight of rats. "
12/01/1986 - "The toxicity of CN-100 was definitely less than that of indometacin, although both drugs were similar in antiinflammatory activity and mode of action on rat paw edema. "
01/01/1987 - "CN-100 exerted potent inhibitory effects on carrageenin-induced acute inflammatory edema and adjuvant-induced arthritis. "
12/01/1986 - "The main metabolite of CN-100 also had a weak antiplatelet effect, and its antiinflammatory effect on carrageenin edema and UV erythema was apparently weaker than that of CN-100. "
12/01/1986 - "The inhibitory effect of CN-100 on carrageenin-induced edema was remarkable and nearly equal to that of indometacin. "

12/01/1986 - "Preventively and therapeutically CN-100 showed potent inhibitory effects on adjuvant primary inflammation and secondary lesion. "
12/01/1986 - "Results suggest that CN-100 is an effective drug on not only acute but also subacute and chronic inflammation."

12/01/1986 - "The main metabolite of CN-100 also had a weak antiplatelet effect, and its antiinflammatory effect on carrageenin edema and UV erythema was apparently weaker than that of CN-100. "
12/01/1986 - "CN-100 exerted a potent inhibitory action on erythema induced by UV irradiation, which was equal to and 3 times stronger than pranoprofen and indometacin in activity, respectively. "

04/01/1991 - "[A long-term evaluation of CN-100 in patients with rheumatoid arthritis]."
02/01/1991 - "[A clinical evaluation of CN-100 in patients with rheumatoid arthritis]."